Case Series Study of Biliary Tract Cancer Patients in Japan
NCT01294085 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2011-11-28
Summary
To assess the difference of prognosis between unresectable and recurrent biliary tract cancer and evaluate prognostic factors.
Conditions
- Biliary Tract Cancer
Sponsors & Collaborators
-
Kansai Hepatobiliary Oncology Group
lead NETWORK
Principal Investigators
-
Tatsuya Ioka, MD · Osaka Medical Center for Cancer and CVD
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-11-30
- Primary Completion
- 2011-02-28
- Completion
- 2011-08-31
Countries
- Japan
Study Locations
More Related Trials
-
Clinicopathologic Characteristics, Progression, and Prognostic Analysis of IPNB
NCT06887023 ·Status: COMPLETED
-
NGS as the First-line Treatment in Advanced Biliary Tract Cancer
NCT04172402 ·Status: COMPLETED ·Phase: PHASE2
-
A Population-Based Case-Control Study of Biliary Tract Cancers in Shanghai, China
NCT00339560 ·Status: COMPLETED
-
Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer
NCT01815307 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract Cancer
NCT02425137 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarker Discovery in Patients With Advanced Biliary Tract Cancer
NCT04871321 ·Status: COMPLETED
-
Gemcitabine Plus S1 and Tislelizumab in the First Line Therapy of Advanced Biliary Tract Carcinoma
NCT05822453 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection
NCT04856761 ·Status: UNKNOWN
-
Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma
NCT04340986 ·Status: RECRUITING
-
The Effect of Individualized Precision Therapy Programs in Patients With BTC
NCT02943031 ·Status: UNKNOWN ·Phase: PHASE4
-
Photodynamic Therapy for Cholangiocarcinoma
NCT04860154 ·Status: COMPLETED ·Phase: NA
-
Study on the Efficacy and Safety of Conversion Therapy in Patients With Initially Unresectable Hepatocellular Carcinoma
NCT06365034 ·Status: RECRUITING
-
Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma
NCT02773485 ·Status: UNKNOWN ·Phase: PHASE3
-
Second Line Therapy in Advanced Biliary Tract Cancer
NCT01530503 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of Chemotherapy Combined With Toripalimab in Advanced Biliary Tract Cancer
NCT03796429 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular Carcinoma
NCT03586973 ·Status: COMPLETED ·Phase: PHASE2
-
Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid Carcinoma
NCT06950814 ·Status: RECRUITING
-
Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma
NCT04993131 ·Status: RECRUITING ·Phase: NA
-
Neoadjuvant Tislelizumab, Gemcitabine, Cisplatin and S-1 for Resectable High-risk Cholangiocarcinoma
NCT06903273 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma
NCT06986486 ·Status: RECRUITING
-
Gemcitabine Plus High-Dose 5-Fu/Leucovorin in the Treatment of Advanced or Metastatic Carcinoma of the Biliary Tract
NCT00201305 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY2157299 in Participants With Unresectable Hepatocellular Cancer (HCC)
NCT02240433 ·Status: COMPLETED ·Phase: PHASE1
-
Dynamic Prediction Model for Patients with Unresectable Biliary Malignancies Receiving Systemic Chemotherapy Combined with Immunotherapy: a Multicenter, Observational Study
NCT06849193 ·Status: RECRUITING
-
Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer
NCT06280508 ·Status: RECRUITING ·Phase: PHASE2
-
S-1 in Combination With Abraxane in Treating Cholangiocarcinoma
NCT01963325 ·Status: COMPLETED ·Phase: PHASE2